Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Levinson

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Urology|March 29, 2000
Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancerF A Critz, W H Williams, J B Benton, et al.
The Cancer Journal From Scientific American|December 16, 1998
Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiationF A Critz, A K Levinson, W H Williams, et al.
Urology|December 22, 1999
Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniquesF A Critz, W H Williams, C T Holladay, et al.
Urology|January 1, 1992
Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomyK I Wishnow, A K Levinson, D E Johnson, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Urology|March 29, 2000
Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancerF A Critz, W H Williams, J B Benton, et al.
The Cancer Journal From Scientific American|December 16, 1998
Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiationF A Critz, A K Levinson, W H Williams, et al.
Urology|December 22, 1999
Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniquesF A Critz, W H Williams, C T Holladay, et al.
Urology|January 1, 1992
Stage B (P2/3A/N0) transitional cell carcinoma of bladder highly curable by radical cystectomyK I Wishnow, A K Levinson, D E Johnson, et al.
Pageof 3